课题基金 / 基金详情

Novel Heterocycles to Study and Develop Therapeutics for Alzheimer’s Disease

Novel Heterocycles to Study and Develop Therapeutics for Alzheimer’s Disease
用于研究和开发阿尔茨海默病治疗方法的新型杂环化合物
批准号：
467007
负责人：
Lee Yui Sun Marvick
金额：
$1.27万
依托单位：
University of Toronto
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-12-01 至 2022-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=467007&lang=en
关键词：
2-A]Indol-1(2h)-Ones 3-Phenylpyrazino[1 Alzheimer'S Disease Amyloid-Beta Aggregation Computational Modeling Drug Discovery Electron Microscopy Studies Fluorescence Kinetics Assay Neuroprotection Studies Organic Chemistry Structure-Based-Design

项目摘要

项目成果

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Alzheimers disease (AD) is a disorder that destroys brain cells, causing thinking abilities and memory to deteriorate over time. As per Alzheimers Society of Canada, a continuously growing population with more than 500,000 Canadians over the age of 65 suf
期刊论文(0)
专著(0)
科研奖励(0)
会议论文